- 全部删除
 
您的购物车当前为空
IR415 选择性地与 HBx 相互作用 (Kd=2 nM) 并阻断 HBV 介导的 RNAi 抑制,逆转 HBx 蛋白对 Dicer 核糖核酸内切酶活性的抑制作用。IR415 具有抗 HBV 的活性。


为众多的药物研发团队赋能,
让新药发现更简单!
IR415 选择性地与 HBx 相互作用 (Kd=2 nM) 并阻断 HBV 介导的 RNAi 抑制,逆转 HBx 蛋白对 Dicer 核糖核酸内切酶活性的抑制作用。IR415 具有抗 HBV 的活性。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 170  | In stock | |
| 5 mg | ¥ 387  | In stock | |
| 10 mg | ¥ 690  | In stock | |
| 25 mg | ¥ 1,390  | In stock | |
| 50 mg | ¥ 2,390  | In stock | |
| 100 mg | ¥ 3,400  | In stock | |
| 200 mg | ¥ 4,730  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 437  | In stock | 
IR415 相关产品
| 产品描述 | IR415 selectively interacts with Hepatitis B virus X protein (HBx, Kd = 2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBx protein on the activity of the dicer endoribonuclease. IR415 is a potent anti-HBV agent and inhibits HBV replication by blocking the HBx activity.  | 
| 靶点活性 |  HBx:2 nM(Kd)  | 
| 体外活性 | IR415 (50-200 μM) has a dose-dependent inhibitory effect on HBx, with a minimal effective concentration of 50 μM in HepG2/GFP-shRNA line transfected with HBx.Hepatitis B virus X protein (HBx) as a suppressor of host defenses consisting of RNAi-based silencing of viral genes.  | 
| 分子量 | 296.34 | 
| 分子式 | C13H14F2N4S | 
| CAS No. | 452967-14-5 | 
| Smiles | Fc1ccc(NC(=S)NCCCn2ccnc2)c(F)c1 | 
| 密度 | 1.32 g/cm3 (Predicted) | 
| 颜色 | White | 
| 物理性状 | Solid | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 125 mg/mL (421.81 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||||||||||||
评论内容